Kwong AJ - Search Results

1

Hepatitis C-positive grafts for hepatitis C-negative recipients in liver transplantation: Buried treasure or depleting resource?

Nakayama T, Krist DT, Akabane M, Imaoka Y, Esquivel CO, Kwong AJ, Kwo PY, Melcher ML, Sasaki K. Nakayama T, et al. Among authors: kwong aj. Liver Transpl. 2024 Dec 17. doi: 10.1097/LVT.0000000000000557. Online ahead of print. Liver Transpl. 2024. PMID: 39679922

2

Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.

Kwong AJ, Wall A, Melcher M, Wang U, Ahmed A, Subramanian A, Kwo PY. Kwong AJ, et al. Am J Transplant. 2019 May;19(5):1380-1387. doi: 10.1111/ajt.15162. Epub 2018 Nov 26. Am J Transplant. 2019. PMID: 30378723 Free PMC article.

3

Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation.

Snyder A, Kojima L, Imaoka Y, Akabane M, Kwong A, Melcher ML, Sasaki K. Snyder A, et al. Liver Transpl. 2023 Aug 1;29(8):793-803. doi: 10.1097/LVT.0000000000000109. Epub 2023 Feb 28. Liver Transpl. 2023. PMID: 36847140

4

Decreased Utilization Rate of Grafts for Liver Transplantation After Implementation of Acuity Circle-based Allocation.

Bekki Y, Myers B, Tomiyama K, Imaoka Y, Akabane M, Kwong AJ, Melcher ML, Sasaki K. Bekki Y, et al. Among authors: kwong aj. Transplantation. 2024 Feb 1;108(2):498-505. doi: 10.1097/TP.0000000000004751. Epub 2023 Aug 16. Transplantation. 2024. PMID: 37585345

5

Overcoming the hurdles of steatotic grafts in liver transplantation: Insights into survival and prognostic factors.

Akabane M, Imaoka Y, Esquivel CO, Melcher ML, Kwong A, Sasaki K. Akabane M, et al. Liver Transpl. 2024 Apr 1;30(4):376-385. doi: 10.1097/LVT.0000000000000245. Epub 2023 Aug 25. Liver Transpl. 2024. PMID: 37616509

6

Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type.

Akabane M, Bekki Y, Inaba Y, Imaoka Y, Esquivel CO, Kwong A, Kim WR, Sasaki K. Akabane M, et al. Liver Transpl. 2024 Sep 18. doi: 10.1097/LVT.0000000000000460. Online ahead of print. Liver Transpl. 2024. PMID: 39287561

7

Beyond 75: Graft Allocation and Organ Utility Implications in Liver Transplantation.

Akabane M, Kwong A, Imaoka Y, Esquivel CO, Kim WR, Melcher ML, Sasaki K. Akabane M, et al. Transplant Direct. 2024 Sep 26;10(10):e1661. doi: 10.1097/TXD.0000000000001661. eCollection 2024 Oct. Transplant Direct. 2024. PMID: 39359941 Free PMC article.

8

Editorial: glecaprevir/pibrentasvir for the treatment of hepatitis C virus-do baseline resistance-associated substitutions matter?

Kwong AJ, Kwo PY. Kwong AJ, et al. Aliment Pharmacol Ther. 2020 Apr;51(7):739-740. doi: 10.1111/apt.15656. Aliment Pharmacol Ther. 2020. PMID: 32162374 No abstract available.

9

Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome.

Kwong A, Kim WR, Kwo PY, Wang U, Cheng X. Kwong A, et al. Liver Transpl. 2021 Aug;27(8):1095-1105. doi: 10.1002/lt.26065. Epub 2021 Jul 14. Liver Transpl. 2021. PMID: 33837624 Free PMC article.

10

Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome.

Kwong AJ, Kim WR, Lake J, Stock PG, Wang CJ, Wetmore JB, Melcher ML, Wey A, Salkowski N, Snyder JJ, Israni AK. Kwong AJ, et al. Transplantation. 2023 Feb 1;107(2):405-409. doi: 10.1097/TP.0000000000004291. Epub 2022 Aug 31. Transplantation. 2023. PMID: 36042548 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters